BNP Paribas Financial Markets’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.8K Buy
9,112
+334
+4% +$970 ﹤0.01% 5079
2025
Q4
$28.1K Sell
8,778
-287
-3% -$720 ﹤0.01% 4925
2025
Q3
$22.8K Sell
9,065
-8,043
-47% -$24.9K ﹤0.01% 4885
2025
Q2
$56.8K Sell
17,108
-3,114
-15% -$11.1K ﹤0.01% 4213
2025
Q1
$84.7K Buy
20,222
+11,667
+136% +$53K ﹤0.01% 4092
2024
Q4
$41.2K Buy
8,555
+850
+11% +$3.98K ﹤0.01% 4503
2024
Q3
$28.4K Sell
7,705
-8,812
-53% -$31.2K ﹤0.01% 3708
2024
Q2
$66.9K Sell
16,517
-49,984
-75% -$213K ﹤0.01% 3387
2024
Q1
$319K Buy
66,501
+12,326
+23% +$71.7K ﹤0.01% 3090
2023
Q4
$410K Buy
54,175
+49,079
+963% +$403K ﹤0.01% 2902
2023
Q3
$52.2K Sell
5,096
-58,033
-92% -$716K ﹤0.01% 3457
2023
Q2
$871K Buy
63,129
+32,830
+108% +$493K ﹤0.01% 2291
2023
Q1
$492K Sell
30,299
-8,292
-21% -$156K ﹤0.01% 2740
2022
Q4
$683K Buy
38,591
+24,313
+170% +$483K ﹤0.01% 2395
2022
Q3
$279K Buy
14,278
+5,383
+61% +$114K ﹤0.01% 3327
2022
Q2
$177K Sell
8,895
-2,476
-22% -$55.3K ﹤0.01% 3141
2022
Q1
$293K Sell
11,371
-471
-4% -$12.2K ﹤0.01% 2990
2021
Q4
$299K Sell
11,842
-9,276
-44% -$257K ﹤0.01% 3246
2021
Q3
$567K Buy
21,118
+14,029
+198% +$404K ﹤0.01% 2686
2021
Q2
$226K Buy
7,089
+860
+14% +$27.3K ﹤0.01% 2843
2021
Q1
$219K Sell
6,229
-2,845
-31% -$99K ﹤0.01% 3001
2020
Q4
$291K Sell
9,074
-6,256
-41% -$193K ﹤0.01% 2709
2020
Q3
$485K Buy
15,330
+9,585
+167% +$317K ﹤0.01% 2234
2020
Q2
$205K Sell
5,745
-5,225
-48% -$181K ﹤0.01% 2485
2020
Q1
$316K Buy
10,970
+4,315
+65% +$113K ﹤0.01% 2612
2019
Q4
$157K Sell
6,655
-35,094
-84% -$786K ﹤0.01% 3074
2019
Q3
$752K Sell
41,749
-38,147
-48% -$630K ﹤0.01% 2002
2019
Q2
$1.25M Buy
79,896
+51,200
+178% +$1.01M ﹤0.01% 1654
2019
Q1
$654K Buy
28,696
+26,922
+1,518% +$607K ﹤0.01% 1926
2018
Q4
$41.3K Sell
1,774
-3,900
-69% -$104K ﹤0.01% 2806
2018
Q3
$187K Buy
5,674
+192
+4% +$7.17K ﹤0.01% 2429
2018
Q2
$241K Sell
5,482
-7,692
-58% -$298K ﹤0.01% 2357
2018
Q1
$550K Buy
13,174
+264
+2% +$12.2K ﹤0.01% 2152
2017
Q4
$587K Sell
12,910
-2,499
-16% -$98.5K ﹤0.01% 2359
2017
Q3
$511K Buy
15,409
+9,138
+146% +$372K ﹤0.01% 1977
2017
Q2
$255K Buy
6,271
+2,167
+53% +$67.1K ﹤0.01% 2302
2017
Q1
$82.7K Buy
4,104
+486
+13% +$10.3K ﹤0.01% 2560
2016
Q4
$83.5K Buy
3,618
+831
+30% +$17.8K ﹤0.01% 2600
2016
Q3
$56.5K Sell
2,787
-3,419
-55% -$68.9K ﹤0.01% 2380
2016
Q2
$116K Buy
6,206
+3,121
+101% +$57.4K ﹤0.01% 2074
2016
Q1
$55.3K Sell
3,085
-623
-17% -$10.7K ﹤0.01% 1971
2015
Q4
$63.6K Sell
3,708
-481
-11% -$8.08K ﹤0.01% 2628
2015
Q3
$67.4K Buy
4,189
+2,503
+148% +$42K ﹤0.01% 2648
2015
Q2
$29.1K Buy
1,686
+1,209
+253% +$20.3K ﹤0.01% 2822
2015
Q1
$7.88K Buy
+477
New +$7.39K ﹤0.01% 2886
2014
Q4
Sell
-1,200
Closed -$16.3K 2866
2014
Q3
$16.3K Buy
1,200
+890
+287% +$12.4K ﹤0.01% 3316
2014
Q2
$4.18K Buy
310
+84
+37% +$1.11K ﹤0.01% 2684
2014
Q1
$2.96K Sell
226
-217
-49% -$3.01K ﹤0.01% 2547
2013
Q4
$7.37K Buy
+443
New +$6.92K ﹤0.01% 2846

Other funds holding PETS

BNP Paribas Financial Markets's PETS Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its PetMed Express (PETS) stake by 3.8% in Q1 2026, buying an estimated $970 and bringing the position to 9,112 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5079.

BNP Paribas Financial Markets first reported a position in PETS in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.25M in Q2 2019. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

  • BNP Paribas Financial Markets held 9,112 shares of PetMed Express worth $20.8K as of Q1 2026.
  • BNP Paribas Financial Markets bought 334 PetMed Express shares in Q1 2026, an estimated $970.
  • PetMed Express made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5079 holding.
  • BNP Paribas Financial Markets first reported a position in PetMed Express in Q4 2013 and has held it in 49 quarters since.
  • BNP Paribas Financial Markets's PetMed Express position peaked at $1.25M in Q2 2019.
  • 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.